Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 1176-1186

  Rokkaku, Takayoshi ^a   Kimura, Ryuichiro ^a   Ishikawa, Chie ^a   Yasumoto, Takeshi ^b   Senba, Masachika ^c   Kanaya, Fuminori ^a   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Okinawa Science and Technology Promotion Center   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Activator protein 1; Akt; Fucoxanthin; Fucoxanthinol; Matrix metalloproteinase 1; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CAROTENOID; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; FUCOXANTHIN; FUCOXANTHINOL; GLYCOGEN SYNTHASE KINASE 3BETA; INTERSTITIAL COLLAGENASE; PROTEIN BCL 2; PROTEIN BCL XL; SURVIVIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL MIGRATION; CELL VIABILITY; CLINICAL EVALUATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG METASTASIS; LUNG NODULE; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA CAROTENE; BONE NEOPLASMS; CAROTENOIDS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; HUMANS; MICE; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-AKT; XANTHOPHYLLS;

EID: 84882371682     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2019     Document Type: Article

References (35)

1. Savage S and Mirabello L: Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011: 548151, 2011.
2. Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AHM, Hogendoorn PCW and Egeler RM: Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 47: 2431-2445, 2011.
3. Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422-441, 2004.
4. Musa-Veloso K, Card JW, Wong AW and Cooper DA: Influence of observational study design on the interpretation of cancer risk reduction by carotenoids. Nutr Rev 67: 527-545, 2009.
5. Peng J, Yuan J-P, Wu C-F and Wang J-H: Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health. Mar Drugs 9: 1806-1828, 2011.
6. Yamamoto K, Ishikawa C, Katano H, Yasumoto T and Mori N: Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas. Cancer Lett 300: 225-234, 2011.
7. Rhim JS, Putman DL, Arnstein P, Huebner RJ and McAllister RM: Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N- nitrosoguanidine. Int J Cancer 19: 505-510, 1977.
8. Hensler PJ, Annab LA, Barrett JC and Pereira-Smith OM: A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 14: 2291-2297, 1994.
9. Zhang C, Ao Z, Seth A and Schlossman SF: A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157: 3980-3987, 1996.
10. Antalis TM and Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucleic Acids Res 19: 4301, 1991.
11. Mori N and Prager D: Transactivation of the interleukin-1 promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87: 3410-3417, 1996.
12. Sherr CJ and Roberts JM: Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711, 2004.
13. Cheng L, Rossi F, Fang W, Mori T and Cobrinik D: Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells. J Biol Chem 275: 30317-30325, 2000.
14. Perkins ND: The diverse and complex roles of NF-B subunits in cancer. Nat Rev Cancer 12: 121-132, 2012.
15. Hayden MS and Ghosh S: Shared principles in NF-B signaling. Cell 132: 344-362, 2008.
16. Iwanaga R, Ohtani K, Hayashi T and Nakamura M: Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 20: 2055-2067, 2001.
17. Zahradka P, Werner JP, Buhay S, Litchie B, Helwer G and Thomas S: NF-B activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol 34: 1609-1621, 2002.
18. Zhu L, Fukuda S, Cordis G, Das DK and Maulik N: Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 508: 369-374, 2001.
19. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR and Lipp J: Nuclear factor (NF)-B-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor-induced apoptosis. J Exp Med 188: 211-216, 1998.
20. Pahl HL: Activators and target genes of Rel/NF-B transcription factors. Oncogene 18: 6853-6866, 1999.
21. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM and Gerondakis S: The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J 19: 6351-6360, 2000.
22. Nicot C, Mahieux R, Takemoto S and Franchini G: Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96: 275-281, 2000.
23. Jin S, Pang R-P, Shen J-N, Huang G, Wang J and Zhou J-G: Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis 12: 1317-1326, 2007.
24. Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274, 2007.
25. Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino F, Piacibello W and Aglietta M: Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res 11: 490-497, 2005.
26. Kimura R, Ishikawa C, Rokkaku T, Janknecht R and Mori N: Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Biochim Biophys Acta 1813: 1543-1553, 2011.
27. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S and Yoshikawa H: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76: 418-422, 1998.
28. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB: NF-B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999.
29. Ali NN, Gilston V and Winyard PG: Activation of NF-B in human osteoblasts by stimulators of bone resorption. FEBS Lett 460: 315-320, 1999.
30. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang H-G, Tsang BK and Cheng JQ: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412, 2004.
31. Liang Y-L, Wang L-Y, Wu H, Ma D-Z, Xu Z and Zha X-L: PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton. Mol Cell Biochem 254: 257-263, 2003.
32. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE and Reusch JE-B: Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766, 2000.
33. Longhi A, Errani C, De Paolis M, Mercuri M and Bacci G: Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32: 423-436, 2006.
34. Gialeli G, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011.
35. Jawad MU, Garamszegi N, Garamszegi SP, Correa-Medina M, Diez JA, Wen R and Scully SP: Matrix metalloproteinase 1: role in sarcoma biology. PLoS One 5: e14250, 2010.